Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 09-1999 | 06-1999 | 03-1999 | 12-1998 | |
| Sales | 1,370 | 1,650 | 960 | -172,940 | 26,090 |
| Cost of Goods | 520 | 430 | 320 | -81,030 | 15,780 |
| Gross Profit | 850 | 1,210 | 630 | -91,900 | 10,300 |
| Operating Expenses | 3,120 | 3,500 | 3,890 | -105,700 | 21,020 |
| Operating Income | -1,750 | -1,850 | -2,930 | 13,760 | -9,930 |
| Interest Expense | 6 | 7 | 6 | -1,550 | 40 |
| Other Income | -224 | -383 | -4 | -6,570 | -960 |
| Pre-tax Income | -1,980 | -2,240 | -2,940 | 8,740 | -10,930 |
| Income Tax | 0 | 0 | 0 | -1,470 | 370 |
| Net Income Continuous | -1,980 | -2,240 | -2,940 | 10,210 | -11,300 |
| Net Income | $-1,980 | $-2,240 | $-2,940 | $10,210 | $-11,300 |
| EBITDA(a) | $-1,610 | $-1,730 | $-3,220 | $14,170 | $-14,070 |